These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 11172695)

  • 1. Adverse reactions to fluoroquinolones. an overview on mechanistic aspects.
    De Sarro A; De Sarro G
    Curr Med Chem; 2001 Mar; 8(4):371-84. PubMed ID: 11172695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential interactions of the extended-spectrum fluoroquinolones with the CNS.
    Lode H
    Drug Saf; 1999 Aug; 21(2):123-35. PubMed ID: 10456380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxicity of quinolones.
    Stahlmann R; Lode H
    Drugs; 1999; 58 Suppl 2():37-42. PubMed ID: 10553703
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Safety of the new fluoroquinolones compared with ciprofloxacin.
    Ball P
    J Chemother; 2000 Jan; 12 Suppl 1():8-11. PubMed ID: 11414383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative tolerability of the newer fluoroquinolone antibacterials.
    Ball P; Mandell L; Niki Y; Tillotson G
    Drug Saf; 1999 Nov; 21(5):407-21. PubMed ID: 10554054
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Central nervous system toxicity of quinolones: human and animal findings.
    Christ W
    J Antimicrob Chemother; 1990 Oct; 26 Suppl B():219-25. PubMed ID: 2124211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Side-effects of quinolones: comparisons between quinolones and other antibiotics.
    Norrby SR
    Eur J Clin Microbiol Infect Dis; 1991 Apr; 10(4):378-83. PubMed ID: 1864300
    [TBL] [Abstract][Full Text] [Related]  

  • 8. History of quinolones and their side effects.
    Rubinstein E
    Chemotherapy; 2001; 47 Suppl 3():3-8; discussion 44-8. PubMed ID: 11549783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety profile of the fluoroquinolones.
    Bertino J; Fish D
    Clin Ther; 2000 Jul; 22(7):798-817; discussion 797. PubMed ID: 10945507
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toxicity of quinolone antimicrobial agents.
    Takayama S; Hirohashi M; Kato M; Shimada H
    J Toxicol Environ Health; 1995 May; 45(1):1-45. PubMed ID: 7752287
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The history of the development and changes of quinolone antibacterial agents].
    Takahashi H; Hayakawa I; Akimoto T
    Yakushigaku Zasshi; 2003; 38(2):161-79. PubMed ID: 15143768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug interactions with fluoroquinolones.
    Stein GE
    Am J Med; 1991 Dec; 91(6A):81S-86S. PubMed ID: 1767807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of side effects of levofloxacin versus other fluoroquinolones.
    Carbon C
    Chemotherapy; 2001; 47 Suppl 3():9-14; discussion 44-8. PubMed ID: 11549784
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of fluoroquinolone antibiotics. Past, present and future.
    Ball P; Tillotson G
    Drug Saf; 1995 Dec; 13(6):343-58. PubMed ID: 8652079
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-activity and structure-side-effect relationships for the quinolone antibacterials.
    Domagala JM
    J Antimicrob Chemother; 1994 Apr; 33(4):685-706. PubMed ID: 8056688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A critical review of the fluoroquinolones: focus on respiratory infections.
    Zhanel GG; Ennis K; Vercaigne L; Walkty A; Gin AS; Embil J; Smith H; Hoban DJ
    Drugs; 2002; 62(1):13-59. PubMed ID: 11790155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Possible role for the new fluoroquinolones (levofloxacin, grepafloxacin, trovafloxacin, clinafloxacin, sparfloxacin, and DU-6859a) in the treatment of anaerobic infections: review of current information on efficacy and safety.
    Goldstein EJ
    Clin Infect Dis; 1996 Dec; 23 Suppl 1():S25-30. PubMed ID: 8953103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sparfloxacin. A review of its antibacterial activity, pharmacokinetic properties, clinical efficacy and tolerability in lower respiratory tract infections.
    Goa KL; Bryson HM; Markham A
    Drugs; 1997 Apr; 53(4):700-25. PubMed ID: 9098667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fluoroquinolone adverse effects and drug interactions.
    Fish DN
    Pharmacotherapy; 2001 Oct; 21(10 Pt 2):253S-272S. PubMed ID: 11642691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence of different profiles of side effects and drug-drug interactions among the quinolones--the pharmacokinetic standpoint.
    Lode H
    Chemotherapy; 2001; 47 Suppl 3():24-31; discussion 44-8. PubMed ID: 11549786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.